Humanized recombinant immunotoxin targeting hCG demonstrates therapeutic potential for advanced stage difficult to treat cancers
- 5 November 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 33 (2) , 281-294
Abstract
We report the development of an immunotherapeutic molecule, a humanized immunotoxin, for treating hCG-expressing advanced-stage cancers. PiPP, a high-affinity anti-hCG monoclonal antibody, is used in the immunotoxin for 'homing' hCG-positive cancer cells. The deimmunized (DI) form of α-Sarcin, a fungal-origin toxin that lacks functional T-cell epitopes, is used in the design to ensure minimal immunogenicity of the immunotoxin for repetitive use in humans. A single-chain variable fragment (scFv) of PiPP was constructed by linking the humanized VH and VL regions of the antibody. The scFv part of the antibody was further linked to the toxin α-Sarcin (DI) at the gene level and expressed as a recombinant protein in E. coli. The immunotoxin was purified from the bacterial cell lysate and analyzed for binding and cytotoxicity to hCG-secreting colorectal and pancreatic cancer cells. The results showed that the scFv(PiPP)-Sarcin immunotoxin was able to bind to colorectal and pancreatic cancer cells and killed approximately 85% of the cells. In vivo testing of the immunotoxin produced results similar to those of in vitro testing against colorectal adenocarcinoma-induced tumors. This immunotoxin could be a promising immunotherapeutic agent for treating colorectal, pancreatic and other terminal-stage hCG-expressing cancers.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
This publication has 41 references indexed in Scilit:
- Pharmaceutical innovation and advanced biotechnology in the biotech-pharmaceutical industry for antibody–drug conjugate developmentDrug Discovery Today, 2024
- Emerging trends and therapeutic applications of monoclonal antibodiesGene, 2024
- Elevated chorionic gonadotropic hormone in transgenic mice induces parthenogenetic activation and ovarian teratomasMolecular and Cellular Endocrinology, 2024
- Expression, purification, and study on the efficiency of a new potent recombinant scFv antibody against the SARS-CoV-2 spike RBD in E. coli BL21Protein Expression and Purification, 2022
- A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC)Cancer Treatment Reviews, 2022
- Bladder cancer metastasis producing beta‐human chorionic gonadotropin, squamous cell carcinoma antigen, granulocyte‐colony stimulating factor, and parathyroid hormone‐related proteinIJU Case Reports, 2018
- Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor VasculatureMolecular Biotechnology, 2016
- Development of a recombinant hCG-specific single chain immunotoxin cytotoxic to hCG expressing cancer cellsProtein Expression and Purification, 2015
- Apoptosis: Identification of dying cellsCell Biology and Toxicology, 1998
- Properties and characteristics of an anti-human chorionic gonadotropin monoclonal antibodyJournal of Biosciences, 1982